NCT05329233

Brief Summary

The aim of our study is to show that continuous oxygen reserve index monitoring is a non-invasive monitoring method that can be used as a supporting parameter to PaO2 in blood gas in hypoxia and hyperoxia monitoring when different fresh gas flow is used in general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 7, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 14, 2022

Completed
Last Updated

April 22, 2022

Status Verified

April 1, 2022

Enrollment Period

5 months

First QC Date

April 7, 2022

Last Update Submit

April 14, 2022

Conditions

Keywords

low flow anesthesiaoxygen reserve indexarterial oxygen pressure

Outcome Measures

Primary Outcomes (1)

  • The use of continuous ORI monitoring as a supporting parameter to PaO2 in blood gasses during hypoxia and hyperoxia

    To show that continuous ORI monitoring is non-invasive monitoring that can be used as a supporting parameter for PaO2 in blood gas in hypoxia and hyperoxia monitoring when different fresh gas flows (4, 1, 0.5 L/min) are used in general anesthesia practice.

    intraoperative period

Secondary Outcomes (1)

  • The use of continuous ORI monitoring as a supporting parameter to PaO2 in blood gasses during hypoxia and hyperoxia

    İntraoperative period

Study Arms (3)

minimal flow

For minimal-flow anesthesia, oxygen 0.3 L/min and medical air 0.2 L/min (FGF 0.5 L/min, FiO2 68%) were administered to patients in group M.

Device: Masimo Radical-7 Pulse CO-Oximeter

low flow

For low-flow anesthesia, oxygen 0.37 L/min and medical air 0.63 L/min (FGF 1 L/min, FiO2 50%) were administered to patients in group L.

Device: Masimo Radical-7 Pulse CO-Oximeter

high flow

For high-flow anesthesia, oxygen 1 L/min and medical air 3 L/min (FGF 4 L/min, FiO2 40%) were administered to patients in group H.

Device: Masimo Radical-7 Pulse CO-Oximeter

Interventions

The Masimo Radical-7 Pulse CO-Oximeter is a device for the measurement of pulse oximetry, oxygen reserve index (ORi), perfusion index (PI), and pleth variability index (PVI). The device is the product of a company called Masimo Inc, Irvine, CA, USA

high flowlow flowminimal flow

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

ASA II and III patients aged between 18-75 years, who were scheduled to undergo elective open abdominal surgery lasting \<60 minutes under general anesthesia

You may qualify if:

  • ASA II and III patients,
  • Aged between 18-75 years,
  • who were scheduled to undergo elective open abdominal surgery lasting \<60 minutes under general anesthesia

You may not qualify if:

  • inability to use the sensor due to finger deformation or hypoperfusion,
  • having a history of malignant hyperthermia,
  • presence of clinically significant anemia, morbid obesity, alcohol or drug addiction, having a severe cardiac, renal or hepatic impairment,
  • having a history of cerebrovascular disease,
  • being a pregnant or presently lactating and having local anesthetic or opioid sensitivity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsun Research and Education Hospital

Samsun, 55090, Turkey (Türkiye)

Location

Related Publications (3)

  • Baxter AD. Low and minimal flow inhalational anaesthesia. Can J Anaesth. 1997 Jun;44(6):643-52; quiz 652-3. doi: 10.1007/BF03015449.

  • Vos JJ, Willems CH, van Amsterdam K, van den Berg JP, Spanjersberg R, Struys MMRF, Scheeren TWL. Oxygen Reserve Index: Validation of a New Variable. Anesth Analg. 2019 Aug;129(2):409-415. doi: 10.1213/ANE.0000000000003706.

  • Scheeren TWL, Belda FJ, Perel A. The oxygen reserve index (ORI): a new tool to monitor oxygen therapy. J Clin Monit Comput. 2018 Jun;32(3):379-389. doi: 10.1007/s10877-017-0049-4. Epub 2017 Aug 8.

Study Officials

  • Zahide Doganay, Professor

    Samsun Research and Education Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

April 7, 2022

First Posted

April 14, 2022

Study Start

January 1, 2020

Primary Completion

June 1, 2020

Study Completion

September 1, 2020

Last Updated

April 22, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

Our data and statistical analysis of each investigated all parameter and data are available after the publication of the clinical study

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The data will be available after the publication of our data upon request from the researchers.
Access Criteria
There is no internet website to obtain data but the researchers can contact Dr. Naci Murat, Ondokuz Mayis University, Samsun, Turkey.

Locations